GB0222409D0 - Use of antitumoral compounds in cancer therapy - Google Patents
Use of antitumoral compounds in cancer therapyInfo
- Publication number
- GB0222409D0 GB0222409D0 GB0222409A GB0222409A GB0222409D0 GB 0222409 D0 GB0222409 D0 GB 0222409D0 GB 0222409 A GB0222409 A GB 0222409A GB 0222409 A GB0222409 A GB 0222409A GB 0222409 D0 GB0222409 D0 GB 0222409D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer therapy
- antitumoral compounds
- antitumoral
- compounds
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0222409A GB0222409D0 (en) | 2002-09-26 | 2002-09-26 | Use of antitumoral compounds in cancer therapy |
EP02801430A EP1435990A1 (en) | 2001-10-19 | 2002-10-18 | Kahalalide compounds for use in cancer therapy |
CA002462639A CA2462639A1 (en) | 2001-10-19 | 2002-10-18 | Kahalalide compounds for use in cancer therapy |
PCT/GB2002/004735 WO2003033012A1 (en) | 2001-10-19 | 2002-10-18 | Kahalalide compounds for use in cancer therapy |
AU2002334203A AU2002334203C1 (en) | 2001-10-19 | 2002-10-18 | Kahalalide compounds for use in cancer therapy |
MXPA04003672A MXPA04003672A (en) | 2001-10-19 | 2002-10-18 | Kahalalide f formulation. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0222409A GB0222409D0 (en) | 2002-09-26 | 2002-09-26 | Use of antitumoral compounds in cancer therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0222409D0 true GB0222409D0 (en) | 2002-11-06 |
Family
ID=9944840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0222409A Ceased GB0222409D0 (en) | 2001-10-19 | 2002-09-26 | Use of antitumoral compounds in cancer therapy |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0222409D0 (en) |
-
2002
- 2002-09-26 GB GB0222409A patent/GB0222409D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL164599A0 (en) | Combination therapy for the treatment of cancer | |
GB0324761D0 (en) | Use of compounds in therapy | |
EP1435988A4 (en) | Improved use of antitumoral compound in cancer therapy | |
EP1482970A4 (en) | Cancer therapy | |
GB0201850D0 (en) | Therapeutic treatment | |
GB0216321D0 (en) | Therapeutic treatment | |
IL173576A0 (en) | Use of polypeptides of the cupredoxin family in cancer therapy | |
AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
HK1078784A1 (en) | Therapeutic treatment | |
GB0223367D0 (en) | Therapeutic treatment | |
EP1539197A4 (en) | Treatment of tumor cells for use in immunotherapy of cancer | |
GB0207410D0 (en) | Compounds and their therapeutic use | |
GB0219660D0 (en) | Therapeutic use | |
IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
LT1496918T (en) | Use of sodium meta-arsenite for the treatment of tumours | |
GB0210741D0 (en) | Methods of therapy | |
GB0210464D0 (en) | Therapeutic treatment | |
GB0226595D0 (en) | Cancer therapy determination | |
AU2003231803A8 (en) | Treatment of cancer with mefloquire | |
EP1583543A4 (en) | Methods and therapeutic compositions in the treatment of advanced cancer | |
GB0329416D0 (en) | Treatment of cancer | |
GB0222409D0 (en) | Use of antitumoral compounds in cancer therapy | |
IL175774A0 (en) | Use of siramesine in the treatment of cancer | |
GB0207409D0 (en) | Benzofuran-2H-3-one compounds and their therapeutic use | |
GB0118627D0 (en) | Use of compounds in therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |